Mechanisms of food protein-derived antihypertensive peptides other than ACE inhibition

Journal of Functional Foods

Volumn 8, Issue 1, 2014, Pages 45-52

  Udenigwe, Chibuike C ^a   Mohan, Aishwarya ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Angiotensin II receptor blockers; Antihypertensive peptides; Arginine nitric oxide; Calcium channel blockers; Endothelin converting enzyme; Renin

Indexed keywords

EID: 84899908460     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2014.03.002     Document Type: Review

References (58)

1. Ajibola C.F., Fashakin J.B., Fagbemi T.N., Aluko R.E. Renin and angiotensin converting enzyme inhibition with antioxidant properties of African yam bean protein hydrolysate and reverse-phase HPLC-separated peptide fractions. Food Research International 2013, 52:437-444.
2. Alashi A.M., Blanchard C.L., Mailer R.J., Agboola S.O., Mawson A.J., He R., Malomo S.A., Girgih A.T., Aluko R.E. Blood pressure lowering effects of Australian canola protein hydrolysates in spontaneously hypertensive rats. Food Research International 2014, 55:281-287.
3. Barba de la Rosa A.P., Montoya A.B., Martínez-Cuevas P., Hernández-Ledesma B., León-Galván M.F., De León-Rodríguez A., González C. Tryptic amaranth glutelin digests induce endothelial nitric oxide production through inhibition of ACE: antihypertensive role of amaranth peptides. Nitric Oxide: Biology and Chemistry 2010, 23:106-111.
4. Chen Z.Y., Peng C., Jiao R., Wong Y.M., Yang N., Huang Y. Anti-hypertensive nutraceuticals and functional foods. Journal of Agricultural and Food Chemistry 2009, 57:4485-4499.
5. Daien V., Duny Y., Ribstein J., Du Cailar G., Mimran A., Villain M., Daures J.P., Fesler P. Treatment of hypertension with renin-angiotensin system inhibitors and renal dysfunction: a systematic review and meta-analysis. American Journal of Hypertension 2012, 25:126-132.
6. Danser A.H.J., Deinum J. Renin, prorenin and the putative (pro)renin receptor. Hypertension 2005, 46:1069-1076.
7. Doyen A., Udenigwe C.C., Mitchell P.L., Marette A., Aluko R.E. Anti-diabetic and antihypertensive activities of two flaxseed protein hydrolysate fractions revealed following their simultaneous separation by electrodialysis with ultrafiltration membranes. Food Chemistry 2014, 145:66-76.
8. Fernández-Musoles R., Castelló-Ruiz M., Arce C., Manzanares P., Ivorra M.D., Salom J.B. Antihypertensive mechanism of lactoferrin-derived peptides: angiotensin receptor blocking effect. Journal of Agricultural and Food Chemistry 2014, 62:173-181.
9. Fernández-Musoles R., López-Díez J.J., Torregrosa G., Valles S., Alborch E., Manzanares P., Salom J.B. Lactoferricin B-derived peptides with inhibitory effects on ECE-dependent vasoconstriction. Peptides 2010, 31:1926-1933.
10. Fernández-Musoles R., Manzanares P., Burguete M.C., En Alborch E., Salom J.B. In vivo angiotensin I-converting enzyme inhibition by long-term intake of antihypertensive lactoferrin hydrolysate in spontaneously hypertensive rats. Food Research International 2013, 54:627-632.
11. Fernández-Musoles R., Salom J.B., Martínez-Maqueda D., López-Díez J.J., Recio I., Manzanares P. Antihypertensive effects of lactoferrin hydrolyzates: inhibition of angiotensin- and endothelin-converting enzymes. Food Chemistry 2013, 139:994-1000.
12. Fisher N.D.L., Hollenberg N.K. Renin inhibition: what are the therapeutic opportunities?. Journal of the American Society of Nephrology 2005, 16:592-599.
13. Fitzgerald C., Gallagher E., Doran L., Auty M., Prieto J., Hayes M. Increasing the health benefits of bread: assessment of the physical and sensory qualities of bread formulated using a renin inhibitory Palmaria palmata protein hydrolysates. LWT - Food Science and Technology 2014, 56:398-405.
14. Fitzgerald C., Mora-Soler L., Gallagher E., O'Connor P., Prieto J., Soler-Vila A., Hayes M. Isolation and characterization of bioactive pro-peptides with in vitro renin inhibitory activities from the macroalga Palmaria palmata. Journal of Agricultural and Food Chemistry 2012, 60:7421-7427.
15. Girgih A.T., Alashi A., He R., Malomo S., Aluko R.E. Preventive and treatment effects of a hemp seed (Cannabis sativa L.) meal protein hydrolysate against high blood pressure in spontaneously hypertensive rats. European Journal of Nutrition 2013, 10.1007/s00394-013-0625-4.
16. Girgih A.T., Udenigwe C.C., Li H., Adebiyi A.P., Aluko R.E. Kinetics of enzyme inhibition and antihypertensive effects of hemp seed (Cannabis sativa L.) protein hydrolysates. Journal of the American Oil Chemists' Society 2011, 88:1767-1774.
17. Harnedy P.A., FitzGerald R.J. In vitro assessment of cardioprotective, anti-diabetic and antioxidant potential of Palmaria palmata protein hydrolysates. Journal of Applied Phycology 2013, 25:1793-1803.
18. He R., Alashi A., Malomo S.A., Girgih A.T., Chao D., Ju X., Aluko R.E. Antihypertensive and free radical scavenging properties of enzymatic rapeseed protein hydrolysates. Food Chemistry 2013, 141:153-159.
19. He R., Malomo S.A., Alashi A., Girgih A.T., Ju X., Aluko R.E. Purification and hypotensive activity of rapeseed protein-derived renin and angiotensin converting enzyme inhibitory peptides. Journal of Functional Foods 2013, 5:781-789.
20. He R., Malomo S.A., Girgih A.T., Ju X., Auko R.E. Glycinyl-histidinyl-serine (GHS), a novel rapeseed protein-derived peptide has blood pressure-lowering effect in spontaneously hypertensive rats. Journal of Agricultural and Food Chemistry 2013, 61:8396-8402.
21. Hong F., Ming L., Yi S., Zhanxia L., Yongquan W., Chi L. The antihypertensive effect of peptides: a novel alternative to drugs?. Peptides 2008, 29:1062-1071.
22. Howard A., Udenigwe C.C. Mechanisms and prospects of food protein hydrolysates and peptide-induced hypolipidaemia. Food & Function 2013, 4:40-51.
23. Inoue H., Takahashi S., Fukui K., Miyake Y. Leucine zipper motif in porcine renin-binding protein (RnBP) and its relationship to the formation of an RnBP-renin heterodimer and an RnBP homodimer. The Journal of Biological Chemistry 1991, 266:11896-11900.
24. Kedzierski R.M., Yanagisawa M. Endothelin system: the double-edged sword in health and disease. Annual Review of Pharmacology and Toxicology 2001, 41:851-876.
25. Law M.R., Morris J.K., Wald N.J. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomized trials in the context of expectations from prospective epidemiological studies. British Medical Journal 2009, 338:b1665.
26. Li H., Aluko R.E. Identification and inhibitory properties of multifunctional peptides from pea protein hydrolysate. Journal of Agricultural and Food Chemistry 2010, 58:11471-11476.
27. Li H., Prairie N., Udenigwe C.C., Adebiyi A.P., Tappia P.S., Aukema H.M., Aluko R.E. Blood pressure lowering effect of a pea protein hydrolysate in hypertensive rats and humans. Journal of Agricultural and Food Chemistry 2011, 59:9854-9860.
28. Maes W., Van Camp J., Vermeirssen V., Hemeryck M., Ketelslegers J.M., Schrezenmeir J., Van Oostveldt P., Huyghebaert A. Influence of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg (ALPMHIR) on the release of endothelin-1 by endothelial cells. Regulatory Peptides 2004, 118:105-109.
29. Martínez-Maqueda D., Miralles B., Recio I., Hernández-Ledesma B. Antihypertensive peptides from food proteins: a review. Food & Function 2012, 3:350-361.
30. Miguel M., Alvarez Y., López-Fandiño R., Alonso J.M., Salaices M. Vasodilator effects of peptides derived from egg white proteins. Regulatory Peptides 2007, 140:131-135.
31. Möller N.P., Scholz-Ahrens K.E., Roos N., Schrezenmeir J. Bioactive peptides and proteins from foods: indication for health effects. European Journal of Nutrition 2008, 47:171-182.
32. Nurminen M.L., Sipola M., Kaarto H., Pihlanto-Leppälä A., Piilola K., Korpela R., Tossavainen O., Korhonen H., Vapaatalo H. Alpha-lactorphin lowers blood pressure measured by radiotelemetry in normotensive and spontaneously hypertensive rats. Life Sciences 2000, 66:1535-1543.
33. Okitsu M., Morita A., Kakitani M., Okada M., Yokogoshi H. Inhibition of the endothelin-converting enzyme by pepsin digests of food proteins. Bioscience, Biotechnology, and Biochemistry 1995, 59:325-326.
34. Onuh J.O., Girgih A.T., Aluko R.E., Aliani M. Inhibitions of renin and angiotensin converting enzyme activities by enzymatic chicken skin protein hydrolysates. Food Research International 2013, 53:260-267.
35. Parr C.L., Keates R.A.B., Bryksa B.C., Ogawa M., Yada R.Y. The structure and function of Saccharomyces cerevisiae proteinase A. Yeast 2007, 24:467-480.
36. Parving H.H., Brenner B.M., McMurray J.J., de Zeeuw D., Haffner S.M., Solomon S.D., Chaturvedi N., Persson F., Desai A.S., Nicolaides M., Richard A., Xiang Z., Brunel P., Pfeffer M.A. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. New England Journal of Medicine 2012, 367:2204-2213. ALTITUDE Investigators.
37. Perna A.F., Ingrosso D., De Santo N.G. Homocysteine and oxidative stress. Amino Acids 2003, 25:409-417.
38. Persson P. Renin: origin, secretion and synthesis. The Journal of Physiology 2003, 552:667-671.
39. Power O., Nongonierma A.B., Jakeman P., Fitzgerald R.J. Food protein hydrolysates as a source of dipeptidyl peptidase IV inhibitory peptides for the management of type 2 diabetes. The Proceedings of the Nutrition Society 2014, 73:34-46.
40. Rahuel J., Rasetti V., Maibaum J., Rueger H., Goschke R., Rüeger H., Göschke R., Cohen N.C., Stutz S., Cumin F., Fuhrer W., Wood J.M., Grütter M.G. Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin. Chemistry & Biology 2000, 7:493-504.
41. Samaranayaka A.G.P., Li-Chan E.C.Y. Food-derived peptidic antioxidants: a review of their production, assessment, and potential applications. Journal of Functional Foods 2011, 3:229-254.
42. Segall L., Covic A., Goldsmith D.J.A. Direct renin inhibitors: the dawn of a new era, or just a variation on a theme?. Nephrology, Dialysis, Transplantation 2007, 22:2435-2439.
43. Sharp S.I., Aarsland D., Day S., Sonnesyn H., Ballard C. Hypertension is a potential risk factor for vascular dementia: systematic review. International Journal of Geriatric Psychiatry 2011, 26:661-669.
44. Sipola M., Finckenberg P., Vapaatalo H., Pihlanto-Leppälä A., Korhonen H., Korpela R., Nurminen M.L. α-lactorphin and β-lactorphin improve arterial function in spontaneously hypertensive rats. Life Sciences 2002, 71:1245-1253.
45. Staessen J.A., Li Y., Richart T. Oral renin inhibitors. Lancet 2006, 368:2124.
46. Takahashi S., Kumagai M., Shindo S., Saito K., Kawamura Y. Renin inhibits N-acetly-D-glucosamine-2-epimerase (renin binding protein). Journal of Biochemistry 2000, 128:951-956.
47. Tanaka M., Tokuyasu M., Matsui T., Matsumoto K. Endothelium-independent vasodilation effect of di- and tri-peptides in thoracic aorta of Sprague-Dawley rats. Life Sciences 2008, 82:869-875.
48. Tanaka M., Watanabe S., Wang Z., Matsumoto K., Matsui T. His-Arg-Trp potently attenuates contracted tension of thoracic aorta of Sprague-Dawley rats through the suppression of extracellular Ca2+ influx. Peptides 2009, 30:1502-1507.
49. Udenigwe C.C., Adebiyi A., Doyen A., Li H., Bazinet L., Aluko R.E. Low molecular weight flaxseed protein-derived arginine-containing peptides reduced blood pressure of spontaneously hypertensive rats faster than amino acid form of arginine and native flaxseed protein. Food Chemistry 2012, 132:468-475.
50. Udenigwe C.C., Aluko R.E. Multifunctional cationic peptide fractions from flaxseed protein hydrolysates. Plant Foods for Human Nutrition 2012, 67:1-9.
51. Udenigwe C.C., Ejike C.E., Quansah J.K., Eze M.O. Towards the management of hypertension: modulation of the renin-angiotensin system by food protein hydrolysates and peptides. Biokemistri 2011, 23:108-117.
52. Udenigwe C.C., Li H., Aluko R.E. Quantitative structure-activity relationship modeling of renin-inhibiting dipeptides. Amino Acids 2012, 42:1379-1386.
53. Udenigwe C.C., Lin Y.S., Hou W.C., Aluko R.E. Kinetics of the inhibition of renin and angiotensin I-converting enzyme by flaxseed protein hydrolysate fractions. Journal of Functional Foods 2009, 1:199-207.
54. Verdecchia P., Angeli F., Mazzotta G., Martire P., Garofoli M., Gentile G., Reboldi G. Aliskiren versus ramipril in hypertension. Therapeutic Advances in Cardiovascular Disease 2010, 4:193-200.
55. 2+ channels. Peptides 2010, 31:2060-2066.
56. Wood J.M., Maibaum J., Rahuel J., Grutter M.G., Cohen N.C., Rasetti V., Rüger H., Göschke R., Stutz S., Fuhrer W., Schilling W., Rigollier P., Yamaguchi Y., Cumin F., Baum H.P., Schnell C.R., Herold P., Mah R., Jensen C., O'Brien E., Stanton A., Bedigian M.P. Structure-based design of aliskiren, a novel orally effective renin inhibitor. Biochemical and Biophysical Research Communications 2003, 308:698-705.
57. World Health Organization World health statistics 2012 2012, Geneva, Switzerland.
58. Yu Z., Yin Y., Zhao W., Chen F., Liu J. Antihypertensive effect of angiotensin-converting enzyme inhibitory peptide RVPSL on spontaneously hypertensive rats by regulating gene expression of the renin-angiotensin system. Journal of Agricultural and Food Chemistry 2014, 62:912-917.